SCHEMBL2155666

SCHEMBL2155666

CCCCCC#CC(CS(=O)(=O)N1CCN(c2ccc(Cl)cc2)CC1)ONC=O

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
GAA P10253 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP3A4 P08684 1/20 0.37
MMP13 P45452 1/20 0.37
MMP14 P50281 1/20 0.37
CNR1 P21554 1/20 0.37
MAPT P10636 3/20 0.36
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
HSD11B1 P28845 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
LSS P48449 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2154992 0.90 LMNA (0.41) GAAMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL2156070 0.89 POLB (0.40) KDM4EMEN1KMT2ACYP3A4MMP13
SCHEMBL2156329 0.88 MMP13 (0.48) KDM4EMEN1KMT2ACYP3A4MMP13
SCHEMBL2154831 0.87 MMP7 (0.36) KDM4EKMT2ACYP3A4MMP13MAPT
SCHEMBL2155252 0.86 POLB (0.38) KDM4EGAAMEN1KMT2ACYP3A4
SCHEMBL2155377 0.86 LMNA (0.38) KDM4EMEN1KMT2ACYP3A4MMP13
SCHEMBL5519230 0.85 DRD2 (0.38) CNR1MAPTTP53LMNA
SCHEMBL16493547 0.85 AR (0.39) KDM4EMAPTPOLBLMNA
SCHEMBL2154936 0.84 MAPT (0.33) KDM4EMEN1KMT2ACYP3A4MMP13
SCHEMBL2155796 0.84 MMP13 (0.50) MEN1KMT2ACYP3A4MMP13MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973039-B2 3-(1,3-benzodioxol-5-yl)-1-({[4-(4-fluorophenyl)-1-piperazinyl]sulfonyl}methyl)-2-propynyl(hydroxy)formamide; analgesics, anticarcinogenic agents, antiarthritic agents; matrix metalloproteinase inhhibitors MERCK SERONO SA (CH) 2011-07-05 US claimed
EP-1828160-A1 SULFONYL AMINO CYCLIC DERIVATIVES AND USE THEREOF AS MMP INHIBITORS LABORATOIRES SERONO S.A. (CH) 2007-09-05 EP claimed
WO-2006067114-A1 SULFONYL AMINO CYCLIC DERIVATIVES AND USE THEREOF LABORATOIRES SERONO S.A. (CH) 2006-06-29 WO claimed